Sponsors & Partners

The Gulf Center for Disease Prevention and Control (Gulf CDC) is a regional public health center that aims at strengthening public health coordination, capacity building and evidence generation across the six member states of the Gulf Cooperation Council (GCC). Gulf CDC is a semi-autonomous technical body of the Gulf Health Council.

The center strategic objectives are to:

• Enable the collection, integration, and utilization of public health data across key indicators through Surveillance and Research.
• Support the development of collaborative public health Programs, Policies, and Ppractices.
• Enhancing Preparedness, Early Detection and Rapid Response to health hazards in the Gulf region.
• Strengthen regional public health Training and Capability Building.

OQ Exploration and Production (OQEP) is a business unit of Oman’s largest global integrated energy group, OQ Group SAOC, specializing in the exploration, drilling, and extraction of oil and gas.

OQEP plays a central role in the OQ energy ecosystem and through its operations aims to maximize the use of Oman’s energy resources while placing the Sultanate at the forefront of energy innovation, excellence and transition, and striving to balance sustainability, energy security, and affordability to contribute to the Sultanate’s national agenda.

OQEP takes its commitment to sustainability and health and safety seriously, viewing it as is a key driver of operational excellence and leveraging cutting edge technologies to continually track and optimize our performance.

Novartis Pharmaceuticals is working to introduce a new vision to the world of medicine to improve and provide a better life for humanity. Novartis is a leader in the innovative pharmaceutical industry.  Every day, we reimagine medicine to improve people’s lives to empower patients, healthcare professionals and communities in the face of serious illnesses. Novartis products reach more than 250 million people globally.

Reimagine your medicine with us: Visit us on  https://www.novartis.com and connect with us on LinkedIn, Facebook, X/Twitter, and Instagram.

Kowa has an almost 130-year history since its founding in 1894 as a cotton fabric wholesaler in Japan. The Kowa Group has now grown into a global enterprise, constantly balancing a progressive spirit and a steady manufacturing spirit. With Kowa Company, Ltd. at its core and over 100 group companies, its business extends around the world in a variety of fields including the trading of textiles, chemicals, machinery, and construction materials, in addition to the manufacturing and sales of medicines, medical devices, vision units, energy saving and energy creating products.

The pharmaceutical business, one of the Kowa Group’s main businesses, covers research and development, manufacturing, and sales of over-the-counter drugs, healthcare products, dietary supplements, drinks, prescription drugs and medical devices (ophthalmological instruments, intraocular lenses, etc.). Bringing its teams together beyond the boundary of business category, Kowa pursues health, wealth and happiness of people.

“Health and Environment” is our vision, with which we create new values through diverse business activities: Visit us on https://www.kowa.co.jp/eng/ where you can see Kowa’s Corporate Profile Video on “About Us”.

Chiesi Rare Disease is a family-owned and -run, Certified B Corporation committed to rare diseases.
As a family business, we deliver innovative therapies and solutions for people affected by rare diseases. Our goal is to ensure equal access so as many people as possible can experience their most fulfilling life.

We are passionate about what we do and compassionate towards individuals with rare diseases, their caregivers, and partners. We listen to and understand the needs of the community that we are privileged to serve, and we aspire to provide them with support throughout their journey. With perseverance and dedication, our team collaborates with the rare disease community around the globe to bring voice to underserved people in the health care system.

With grit, determination and urgency, we are committed to removing obstacles to provide people affected by rare diseases with the tools they need while overcoming disparities and contributing to the societal imperative of ensuring health for people of all ages.

We leverage our entrepreneurial spirit, integrity and drive to make a substantial difference in the lives of people with rare diseases and their families: We are making a rare difference.

Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Our belief—and the core of our strategy—is that innovative, highly differentiated medicines that provide large clinical benefits in addressing serious diseases are medicines that will not only help patients, but also will help reduce the social and economic burden of disease in society today.

At Business International Group LLC, Healthcare and Life Science division we pride ourselves on being your trusted partners in the realm of life sciences. Our dedicated team of professionals is committed to guiding you towards the ideal solutions tailored to your specific area of interest. Whether you’re seeking cutting-edge technology for diagnostics or innovative equipment for stem cell research, we have you covered.

With years of experience, we understand that technical support is paramount. Our knowledgeable experts are readily available to provide the assistance you need. We ensure that you are equipped with not only the right products but also the guidance to make the most of them. From answering inquiries to troubleshooting, we’re here to facilitate your journey every step of the way.

We comprehend the importance of seamless operations, which is why we offer a robust system of periodic maintenance. Our seasoned service specialists are dedicated to upholding the performance and reliability of your systems.

Our dedicated team of professionals, consisting of seasoned Microbiologists, Biochemists, Molecular Biologists, and experienced Service Engineers, stands ready to provide unwavering support for all your application requirements.

At Menagen, we are dedicated to helping patients with rare and difficult to manage diseases .

Our high-tech production facility in Oman meets the highest global standards, based on international regulated authorities allowing us to bring new therapies to improve patients’ quality of life.

Our state-of-the-art facility enables us to accelerate the access of innovative medicines from regulated authorities to the MENAT region. Our focus is on local manufacturing, working with global partners, and always putting patients’ first.

Menagen is committed to operating with honesty and transparency, while continuing to develop new, affordable treatments that can make a real difference.

Our Vision: To be a regional leader in innovative therapies and biosimilars, focusing on rare diseases and unmet patient needs.

At Abbott, we’re dedicated to helping people live more fully, in everything we do. We’re creating the future of healthcare through life-changing technologies and products that make you healthier and stronger, quickly identify when you have a medical need, and treat conditions to help you get back to doing what you love. Founded in Chicago 135 years ago, Abbott is currently serving people in more than 160 countries with leading medical devices, diagnostics, nutrition products and branded generic medicines. Our 115,000 colleagues are helping millions of people to live better and healthier.

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Novo Nordisk’ purpose is to drive change to defeat serious chronic diseases, built upon their heritage in diabetes. They do so by pioneering scientific breakthroughs, expanding access to their medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 64,000+ people in 80 countries and markets its products in around 170 countries.

We are a leading global energy producer based in Oman. Our focus on creating value, driving sustainability, and advancing renewable energy initiatives, while expanding our presence in the oil and gas sector.

Established in 1968, Muscat Pharmacy & Stores LLC has evolved itself over the years, and emerged as the largest pharmaceutical distributor chain in the Sultanate of Oman.  With over 67+ plus retail   outlets spread across the country, ensuring that medical products are easily accessible to patients even in remote locations.  Muscat Pharmacy remains as the largest supplier of healthcare products to   government institutions, as well as to various private hospitals in Oman.  The company has all necessary warehousing and distribution infrastructure established on a strong platform, and has the unique   distinction to be the first pharmacy in Oman to be certified ISO 9002: 1994, way back in 1990.

Abraj Energy Services S.A.O.G (Abraj) stands as a linchpin in Oman’s oil and gas ecosystem, established in the pivotal year of 2006. Over the years, the company has exhibited remarkable growth, ascending to the position of Oman’s preeminent oilfield drilling enterprise. Boasting one of the most modern and youthful drilling fleets in the Gulf Cooperation Council (GCC), Abraj has cultivated a robust reputation in the local and regional markets.

Through strategic diversification, the company has expanded its array of services to include avant-garde drilling techniques, well services operations, and comprehensive integrated project management solutions. This multifaceted approach has been pivotal in securing long-term contractual relationships with leading national and international exploration and production companies.
Capitalising on a formidable network of suppliers, the company has seamlessly incorporated state-of-the-art technologies into its service portfolio, ensuring cost-effectiveness without compromising quality. This agile approach has been further enhanced by a highly skilled workforce committed to upholding stringent safety and efficiency standards across all operational sectors.
As an affiliate of OQ, an international conglomerate specialising in the oil and gas sector, Abraj enjoys robust institutional backing. The Omani government holds a significant 51% stake in the company, while the remaining 49% is publicly traded on the Muscat Stock Exchange, solidifying its reputation as a reliable and transparent entity.”

Our Vision
To be the energy market leader for the services we provide. Through our human capital and industrial resources, we aspire to be a service-based company of world-class caliber. To revolutionize the sector, we will strive to adapt to environmental and innovative advancements.

Our Mission
To deliver secure and high-quality services; guided by global business standards, while creating value for our clients, shareholders, employees and the community in which we operate.

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Twitter, LinkedIn and YouTube.

Oman Liquefied Natural Gas LLC (Oman LNG) is a Joint Venture established by a Royal Decree in 1994, and operates under the laws of the Sultanate of Oman. The Company produces and sells Liquefied Natural Gas (LNG) and its by-product, Natural Gas Liquids (NGLs).

Oman LNG directly and indirectly undertake project operations and related activities essential to liquefy, store, transport and market Oman’s natural gas and to deliver LNG to customers. At its plant in Sur, the company is currently operating three (3) liquefaction trains at our site which have an enhanced production capacity of 11.4 million tonnes per annum (mtpa). Our activities contribute to the Oman Government’s objective of diversifying the economy.

Oman LNG has partnered with some of the world’s leading energy companies, including several Japanese firms. This partnership has played a pivotal role in strengthening Oman’s bilateral relations with Japan.

In 2000, Oman LNG shipped its first cargo to Japan. In 2023, Oman LNG achieved a milestone by signing binding term sheet agreements with three Japanese firms: Itochu, Jera, and Mitsui & Co. These agreements highlight Oman LNG’s strong relationship with Japan and the company’s commitment to further collaboration and partnerships in the future.

Algorithm is a regional pharmaceutical company committed to improving human health and well-being, operating in the Middle East and North Africa (MENA) region.

We focus on innovative products either under license from international companies or differentiated generics in these therapeutic lines:

Blood Thinners, Diabetes & Obesity, Dyslipidemia & Hypertension, Neurology & Psychiatry, & Primary Care.

Its dedicated and talented team of highly skilled personnel has built a culture and reputation based on Trust and Respect, Ethics and Integrity, Responsibility and Accountability, Quality and Excellence.

National pharmaceutical Industries, NPI is the 1st pharmaceutical manufacturer in Oman, it was established in 2001, in Rusayl Industrial Estate, Muscat.

NPI is a USFDA and EUGMP approved facility with two plants a B lactam plant and Main plant in Oman. it owns two more facilities; Elixir UAE & Elixir KSA.

NPI has 169 registered products in Oman, with registered products in GCC, Jordan, Iraq, Yemen, Sudan, African countries, CIS& Europe.

Kaneka Medical Europe N.V.

Kaneka Corporation (Kaneka) was founded in 1949 in Osaka, Japan, and has a long, successful corporate history. Kaneka is renowned for its innovative technologies applied in its medical products, as well as for providing intermediates used as pharmaceutical active ingredients, macromolecules, in fermentation and in the life sciences. Today, Kaneka has subsidiaries in the USA, Belgium, Germany, Singapore, Malaysia, Australia, China, Vietnam, India, Taiwan, and South Korea. Kaneka Corporation is also the parent company of Kaneka Medical Europe N.V. (KME), which focuses on lipoprotein apheresis in the EMEA market, and interventional products in the field of neuroradiology, both core parts of the company’s main business.

Philex is a pharmaceutical company headquartered in the Sultanate of Oman, and located in Salalah. Philex has the latest manufacturing technologies and multinational partnerships that allow us to manufacture and package high-quality pharmaceuticals and biopharmaceutical products that cover a wide range of therapeutic areas. By ensuring the availability and quality of our products, we achieve pharmaceutical security in the region at competitive prices.

To receive more information about the Congress and available sponsorship opportunities, fill out the fields below and the support prospectus will be emailed.